Incidental Mutation 'IGL00897:Neurod2'
ID 28468
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Neurod2
Ensembl Gene ENSMUSG00000038255
Gene Name neurogenic differentiation 2
Synonyms Ndrf, bHLHa1
Accession Numbers
Essential gene? Probably essential (E-score: 0.792) question?
Stock # IGL00897
Quality Score
Status
Chromosome 11
Chromosomal Location 98216241-98220471 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to T at 98218595 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Methionine at position 190 (V190M)
Ref Sequence ENSEMBL: ENSMUSP00000041373 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000041685]
AlphaFold Q62414
Predicted Effect probably damaging
Transcript: ENSMUST00000041685
AA Change: V190M

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000041373
Gene: ENSMUSG00000038255
AA Change: V190M

DomainStartEndE-ValueType
low complexity region 34 57 N/A INTRINSIC
low complexity region 76 111 N/A INTRINSIC
HLH 128 180 4.19e-17 SMART
Pfam:Neuro_bHLH 181 311 5.7e-43 PFAM
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the neuroD family of neurogenic basic helix-loop-helix (bHLH) proteins. Expression of this gene can induce transcription from neuron-specific promoters, such as the GAP-43 promoter, which contain a specific DNA sequence known as an E-box. The product of the human gene can induce neurogenic differentiation in non-neuronal cells in Xenopus embryos, and is thought to play a role in the determination and maintenance of neuronal cell fates. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for a targeted null mutation show elevated neuronal apoptosis resulting in ataxia, incoordination, elevated seizure susceptibility, and death by 35 days. Heterozygotes are moderately affected, and adults are subject to unexplained death. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 35 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca14 T C 7: 119,815,348 (GRCm39) probably benign Het
Arsi A G 18: 61,045,502 (GRCm39) Y64C probably damaging Het
Ascc3 A T 10: 50,604,187 (GRCm39) E1302D probably benign Het
Aspm T C 1: 139,405,145 (GRCm39) I1344T probably damaging Het
Atp2b1 T C 10: 98,850,882 (GRCm39) I924T possibly damaging Het
Ccnb1 A G 13: 100,922,419 (GRCm39) probably benign Het
Cps1 A G 1: 67,254,723 (GRCm39) D1304G probably benign Het
Ctsq C A 13: 61,185,539 (GRCm39) V201F probably damaging Het
Efcab3 G A 11: 104,990,847 (GRCm39) D293N probably damaging Het
Epb41 T A 4: 131,727,508 (GRCm39) probably null Het
Fat2 T C 11: 55,180,078 (GRCm39) E1421G probably damaging Het
Flt1 T A 5: 147,526,664 (GRCm39) Y873F probably benign Het
Fos C T 12: 85,523,120 (GRCm39) T344I probably damaging Het
Gsdme A G 6: 50,206,264 (GRCm39) probably null Het
Inpp5d A G 1: 87,639,836 (GRCm39) T846A probably benign Het
Insyn2b T C 11: 34,353,011 (GRCm39) V351A probably benign Het
Kdm4c T C 4: 74,291,921 (GRCm39) M846T probably damaging Het
Lrp2 A G 2: 69,352,225 (GRCm39) F604L possibly damaging Het
Mab21l3 C A 3: 101,730,771 (GRCm39) R156L probably damaging Het
Mrps9 A G 1: 42,944,619 (GRCm39) E379G probably damaging Het
Myo16 T C 8: 10,365,518 (GRCm39) L119P probably damaging Het
Nprl2 T G 9: 107,422,727 (GRCm39) N371K probably benign Het
Nr1d2 A T 14: 18,214,993 (GRCm38) C340S probably benign Het
Nsg1 A T 5: 38,302,060 (GRCm39) V117D probably damaging Het
Or6c219 A T 10: 129,781,780 (GRCm39) D50E possibly damaging Het
Or7e168 T G 9: 19,719,917 (GRCm39) V101G probably damaging Het
Paqr4 T C 17: 23,956,544 (GRCm39) D273G possibly damaging Het
Plcb4 A G 2: 135,813,718 (GRCm39) T686A probably benign Het
Ppp1r8 G A 4: 132,555,213 (GRCm39) A335V probably damaging Het
Slc4a2 T A 5: 24,634,557 (GRCm39) Y65* probably null Het
Slco3a1 A T 7: 74,153,931 (GRCm39) Y214N probably damaging Het
Tmem232 T C 17: 65,563,569 (GRCm39) E608G possibly damaging Het
Vmn1r169 A T 7: 23,277,019 (GRCm39) Y137F probably damaging Het
Vmn2r97 T C 17: 19,167,921 (GRCm39) I725T probably benign Het
Vmn2r98 T A 17: 19,286,007 (GRCm39) probably benign Het
Other mutations in Neurod2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01751:Neurod2 APN 11 98,218,201 (GRCm39) missense possibly damaging 0.94
IGL01752:Neurod2 APN 11 98,218,201 (GRCm39) missense possibly damaging 0.94
IGL02661:Neurod2 APN 11 98,218,405 (GRCm39) missense possibly damaging 0.65
hesitate UTSW 11 98,218,582 (GRCm39) missense probably damaging 1.00
R5181_Neurod2_559 UTSW 11 98,218,204 (GRCm39) missense probably benign 0.43
selection UTSW 11 98,218,147 (GRCm39) missense probably benign 0.01
PIT4362001:Neurod2 UTSW 11 98,218,708 (GRCm39) missense probably damaging 1.00
R0904:Neurod2 UTSW 11 98,218,147 (GRCm39) missense probably benign 0.01
R0989:Neurod2 UTSW 11 98,218,805 (GRCm39) missense probably damaging 1.00
R1290:Neurod2 UTSW 11 98,218,114 (GRCm39) missense possibly damaging 0.69
R1564:Neurod2 UTSW 11 98,218,250 (GRCm39) missense probably damaging 0.96
R1712:Neurod2 UTSW 11 98,218,029 (GRCm39) missense probably damaging 1.00
R1901:Neurod2 UTSW 11 98,218,558 (GRCm39) missense probably damaging 1.00
R2129:Neurod2 UTSW 11 98,218,414 (GRCm39) missense possibly damaging 0.73
R2267:Neurod2 UTSW 11 98,218,582 (GRCm39) missense probably damaging 1.00
R3754:Neurod2 UTSW 11 98,218,526 (GRCm39) missense probably damaging 1.00
R4421:Neurod2 UTSW 11 98,219,026 (GRCm39) nonsense probably null
R5067:Neurod2 UTSW 11 98,218,063 (GRCm39) missense possibly damaging 0.71
R5181:Neurod2 UTSW 11 98,218,204 (GRCm39) missense probably benign 0.43
R7922:Neurod2 UTSW 11 98,218,454 (GRCm39) missense probably benign 0.00
R7976:Neurod2 UTSW 11 98,218,023 (GRCm39) missense probably damaging 0.97
R8692:Neurod2 UTSW 11 98,218,960 (GRCm39) missense probably benign 0.02
R8842:Neurod2 UTSW 11 98,218,507 (GRCm39) missense probably damaging 1.00
R9716:Neurod2 UTSW 11 98,218,444 (GRCm39) missense probably damaging 1.00
Posted On 2013-04-17